Atlas Trials

Participant Centered Active Surveillance for Adverse Event Following Measles Immunization in Gedeo Zone, Ethiopia, 2022. A Multi-center Open-label Randomized Control Trial

Clinical trial NCT05803538 · UNKNOWN

Trial details

NCT number
NCT05803538
Sponsor
Dilla University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Measles
Start date
2023-05-15
Primary completion
2023-12-20
Enrollment
391

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.